HRT FINANCIAL LP sold $373K of SHPH
HRT FINANCIAL LP sold 83,149 shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at an average of $4.48 ($4.48–$4.67, $0.37M total) across 2 trades over 2026-07-13 to 2026-07-14.
How this was made
The 30-second read
Why it matters
A 10% owner sold shares over two days at $4.48 to $4.67, reducing holdings to zero. This can modestly affect sentiment but does not introduce new operational or regulatory information.
Market read
Traders may monitor for follow-on selling or changes in insider ownership, but the disclosure alone is unlikely to drive a durable repricing.
What to watch
The filing does not confirm whether the sale was part of a 10b5-1 plan (it says no), so traders may overinterpret intent without additional context like prior filings or subsequent transactions.
Background
The article is an SEC Form 4 insider transaction disclosure for Shuttle Pharmaceuticals Holdings, Inc.
Ticker impact
HRT Financial LP, a 10% owner, sold 83,149 Shuttle Pharmaceuticals shares in open-market trades for about $372.7K, leaving 0 shares.
Likely limited near-term impact; any effect would be sentiment-driven and should fade unless follow-on selling appears.
Form 4 shows the transaction details and post-sale holdings, but provides no new company-specific operating or regulatory catalyst.
Market effects
No clear sector read-through from a single disclosed insider sale without accompanying company news.
None indicated.
None indicated.
Counterpoint
The holder may be rebalancing or meeting liquidity needs; insider sales are common and do not necessarily signal deteriorating fundamentals.
Key entities
- issuerShuttle Pharmaceuticals Holdings, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderHRT Financial LP
10% owner who executed the open-market sale.